Education
About Us
Working with TipRanks
Follow Us
Shanghai Haohai Biological Technology Co., Ltd. Class H (HK:6826)
:6826
6826 Stock Chart & Stats
HK$24.90
-HK$0.40(-1.57%)
At close: 4:00 PM EST
HK$24.90
-HK$0.40(-1.57%)
Day’s Range― - ―
52-Week RangeHK$21.70 - HK$34.35
Previous CloseN/A
Volume220.22K
Average Volume (3M)211.55K
Market Cap
HK$11.05B
Enterprise ValueHK$6.65B
Total Cash (Recent Filing)HK$2.60B
Total Debt (Recent Filing)HK$412.87M
Price to Earnings (P/E)14.8
Beta0.80
Next Earnings
Mar 21, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.28%
Share Statistics
EPS (TTM)0.45
Shares Outstanding36,509,740
10 Day Avg. Volume238,704
30 Day Avg. Volume211,551
Financial Highlights & Ratios
PEG Ratio-0.53
Price to Book (P/B)1.05
Price to Sales (P/S)2.18
P/FCF Ratio20.61
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Profitability MarginsHigh profitability margins indicate effective cost management and pricing power, supporting long-term financial stability and competitive positioning.
Low LeverageLow leverage reduces financial risk and interest obligations, providing the company with greater flexibility to invest in growth opportunities.
Positive Cash Flow TrendGrowing free cash flow enhances the company's ability to fund operations, invest in R&D, and return capital to shareholders, supporting sustainable growth.
Bears Say
Declining RevenueDeclining revenue can signal weakening demand or competitive pressures, which may impact long-term growth prospects and market share.
Negative EBIT MarginA negative EBIT margin suggests operational inefficiencies or cost pressures, which could hinder profitability and require strategic adjustments.
Revenue Growth ChallengesOngoing revenue growth challenges may limit the company's ability to scale operations and invest in new market opportunities, affecting long-term competitiveness.
Shanghai Haohai Biological Technology Co., Ltd. Class H News
6826 FAQ
What was Shanghai Haohai Biological Technology Co., Ltd. Class H’s price range in the past 12 months?
Shanghai Haohai Biological Technology Co., Ltd. Class H lowest stock price was HK$21.70 and its highest was HK$34.35 in the past 12 months.
What is Shanghai Haohai Biological Technology Co., Ltd. Class H’s market cap?
Shanghai Haohai Biological Technology Co., Ltd. Class H’s market cap is HK$11.05B.
When is Shanghai Haohai Biological Technology Co., Ltd. Class H’s upcoming earnings report date?
Shanghai Haohai Biological Technology Co., Ltd. Class H’s upcoming earnings report date is Mar 21, 2026 which is in 26 days.
How were Shanghai Haohai Biological Technology Co., Ltd. Class H’s earnings last quarter?
Shanghai Haohai Biological Technology Co., Ltd. Class H released its earnings results on Oct 24, 2025. The company reported HK$0.448 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.448.
Is Shanghai Haohai Biological Technology Co., Ltd. Class H overvalued?
According to Wall Street analysts Shanghai Haohai Biological Technology Co., Ltd. Class H’s price is currently Overvalued.
Does Shanghai Haohai Biological Technology Co., Ltd. Class H pay dividends?
Shanghai Haohai Biological Technology Co., Ltd. Class H pays a Quarterly dividend of HK$0.438 which represents an annual dividend yield of 4.28%. See more information on Shanghai Haohai Biological Technology Co., Ltd. Class H dividends here
What is Shanghai Haohai Biological Technology Co., Ltd. Class H’s EPS estimate?
Shanghai Haohai Biological Technology Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Shanghai Haohai Biological Technology Co., Ltd. Class H have?
Shanghai Haohai Biological Technology Co., Ltd. Class H has 36,509,740 shares outstanding.
What happened to Shanghai Haohai Biological Technology Co., Ltd. Class H’s price movement after its last earnings report?
Shanghai Haohai Biological Technology Co., Ltd. Class H reported an EPS of HK$0.448 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.325%.
Which hedge fund is a major shareholder of Shanghai Haohai Biological Technology Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:6826
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Shanghai Haohai Biological Technology Co., Ltd. Class H Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
6.53%
12-Months-Change
Fundamentals
Return on Equity
6.69%
Trailing 12-Months
Asset Growth
-3.01%
Trailing 12-Months
Company Description
Shanghai Haohai Biological Technology Co., Ltd. Class H
Shanghai Haohai Biological Technology Co., Ltd. is a leading biotechnology company based in Shanghai, China, specializing in the research, development, production, and commercialization of innovative medical devices and biopharmaceuticals. The company primarily operates in the fields of surgical sutures, wound care products, and regenerative medicine, focusing on enhancing patient outcomes through advanced technology and high-quality products. Haohai is committed to innovation and is dedicated to providing superior healthcare solutions to both domestic and international markets.
Shanghai Haohai Biological Technology Co., Ltd. Class H (6826) Earnings & Revenues
Technical Analysis
Ascletis Pharma, Inc.
―
Lepu Biopharma Co. Ltd. Class H
―
Keymed Biosciences, Inc.
―
CARsgen Therapeutics Holdings Ltd.
―
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
―
Options Prices
Currently, No data available
---